特刊主题：
Emerging Mechanisms and Therapeutic Targets in Cardiovascular Immunology
投稿截止日期：2023年3月31日
投稿链接：https://fasebj.msubmit.net/cgi-bin/main.plex
特刊介绍
Cardiovascular diseases (CVDs) such as heart attacks, ischemic stroke, and peripheral artery disease remain the main cause of death worldwide, despite substantial advances in interventional treatment and risk factor management. Crosstalk between the immune system and the cardiovascular system drives CVDs. Atherosclerosis, the main underlying pathology of CVDs, has been established as a chronic inflammatory condition. The concept of “residual inflammatory risk” offers potential targeting strategies for cardiovascular prevention. Likewise, compelling evidence implicates the immune system as an acute contributor to ischemic heart disease and heart failure. Many levels of crosstalk have been identified, yet, the precise networks and mechanisms are not completely understood, resulting in very few immunotherapeutic treatments for CVDs in the clinic.
In this Special Collection, we aim to assemble work that contributes to the discovery and understanding of novel cellular, molecular, and metabolic mechanisms in cardiovascular immunology, including but not limited to:
- studies of alarmins, cytokines, and chemokines;
- interactions between immune cells and endothelial cells, cardiac stromal cells, cardiomyocytes, or cardiac macrophages;
- changes in immunometabolism;
- studies that address the promises (but also potential limitations) of emerging therapeutic targets in this area.
The goal is to summarize recent advances in this highly dynamic and exciting field of biomedical research that will be useful for both basic cardiovascular scientists and immunologists, as well as translational scientists and clinicians. COVID-19-related contributions impacting the cardiovascular system are explicitly encouraged. We welcome Original Research Articles, Perspectives, Hypothesis Articles, and Review Articles.
关键词
cytokine, chemokine, inflammation, immunity, atherosclerosis, precision medicine, ischemia, cardiovascular disease
投稿须知
投稿截止日期：2023年3月31日
投稿链接：https://fasebj.msubmit.net/cgi-bin/main.plex
投稿时请在Special Collection 相关问题的下拉菜单中选择此特刊主题：“Emerging Mechanisms and Therapeutic Targets in Cardiovascular Immunology”，并在cover letter中注明是此特刊的投稿，以确保您的稿件能准确提交和被及时处理。
本特刊将以虚拟特刊形式呈现，所有文章一经接收将直接在期刊发表。待全部发表后，所有文章会收录于此专题的虚拟特刊合集中。
欢迎扫描以下二维码，浏览期刊的作者指南，以了解文章类型及其他投稿要求：
https://faseb.onlinelibrary.wiley.com/hub/journal/15306860/homepage/author-guidelines
客座编辑
Jürgen Bernhagen, PhD
Institute for Stroke and Dementia Research (ISD)
Ludwig-Maximilians-University (LMU)
Munich, Germany
E-Mail: juergen.bernhagen@med.uni-muenchen.de
Internet: http://BernhagenLab.isd-muc.de
期刊介绍
Editor-in-Chief：Thoru Pederson (University of Massachusetts, US)
期刊主页：https://faseb.onlinelibrary.wiley.com/journal/15306860
The FASEB Journal 是美国实验生物学学会联合会（Federation of American Societies for Experimental Biology, FASEB）官方刊物，旨在发表多学科融合的高质量和有影响力的研究结果，涵盖生物和生物医学领域里的各个层次：从原子，分子，细胞，到组织，器官，有机体，乃至种群等。期刊欢迎基础与转化研究，以及临床前和早期临床研究的文章投稿。
期刊最新影响因子：5.834，5年平均影响因子：6.103，Journal Citation Indicator (JCI)：0.99，CiteScore 2021：7.9，SNIP 2021：1.104。
期刊的中科院分区为：大区生物学2区，小区生化与分子生物学2区，生物学2区，细胞生物学3区。
期刊文章处理速度：一审平均时间19.40天，一审时间中值20.73天。
声 明
